JPX · 4519.T
Chugai Pharmaceutical Co., Ltd.
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
Loading market information…
JPX · 2413.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
M3, Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.98% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
M3, Inc.’s forward annual dividend is ¥22 per share, paid annual. The forward yield is 1.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
M3, Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of ¥19. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow M3, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:37 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ¥12-23.29% vs estimate |
| ¥79.38B+1.15% vs estimate |
| Q3 2025 | Feb 10, 2025 | ¥22+24.36% vs estimate | ¥80.7B+3.68% vs estimate |
|---|
| Q2 2025 | Oct 30, 2024 | ¥9-35.76% vs estimate | ¥60.61B-5.29% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
¥3,690+¥15 (+0.41%)
JMDC Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.45% below the high.
¥2,588+¥79 (+3.15%)
SMS Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.03% below the high.
¥2,386+¥33 (+1.4%)
Medley, Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.51% below the high.
¥11,530+¥120 (+1.05%)
Software Service, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.04% below the high.
¥1,490+¥66 (+4.63%)
Value HR Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.54% below the high.
¥563+¥2 (+0.36%)
EM Systems Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.06% below the high.
¥1,633¥0 (0.0%)
CE Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.16% below the high.
